Cintirorgon (LYC-55716) is a first-in-class, selective and orally bioavailable RORgamma agonist. Cintirorgon (LYC-55716) modulates gene expression of RORgamma expressing T lymphocyte immune cells, resulting in enhanced effector function, as well as decreased immunosuppression, resulting in decreased tumor growth, and improved survival[1][2].
Molekulargewicht:
603.53
Reinheit:
99.95
CAS Nummer:
[2055536-64-4]
Formel:
C27H23F6NO6S
Target-Kategorie:
ROR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten